Compared with UDCA monotherapy, the AST, ALP, TBIL, IgG, and IgM levels were significantly attenuated by combination therapy in PBC patients, but there were no significant changes of serum biochemical index such as ALT and GGT. The gene discussed is CD40LG; the disease is primary biliary cholangitis.